Emcure Pharma IPO: The bidding for the initial public offering (IPO) of Emcure Pharmaceuticals Limited concluded on Friday last week, with the public issue worth ₹1,952.03 crore receiving a robust response from the Indian primary market investors. The Emcure Pharma IPO subscription status reveals that the public issue was oversubscribed […]

Edelweiss MD and CEO Radhika Gupta, recently shared valuable insights on X (formerly Twitter) from their factor investing team, supported by detailed charts and data. In her first tweet, Gupta highlighted the performance of various investment factors over the past decade, revealing that momentum has been the best-performing factor, significantly […]